Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Population pharmacokinetics of recombinant factor VIII: the relationships of pharmacokinetics to age and body weight

Sven Björkman, MyungShin Oh, Gerald Spotts, Phillip Schroth, Sandor Fritsch, Bruce M. Ewenstein, Kathleen Casey, Kathelijn Fischer, Victor S. Blanchette, Peter W. Collins

Blood (2012) 119 (2): 612–618.

https://doi.org/10.1182/blood-2011-07-360594

Published: 2012

Includes: Supplemental data

Journal Articles

Use of a Population Pharmacokinetic Model of ADVATE In Pediatric and Adult Patients with Hemophilia A Permits Limited Blood Sampling for Individual Dose Tailoring.

MyungShin Oh, Sven Björkman, Phillip Schroth, Sandor Fritsch, Peter W Collins, Kathelijn Fischer, Victor S. Blanchette, Kathleen M. Casey, Gerald Spotts, Bruce M. Ewenstein

Blood (2010) 116 (21): 1416.

https://doi.org/10.1182/blood.V116.21.1416.1416

Published: 2010

Journal Articles

Population Pharmacokinetic Model of ADVATE in Pediatric and Adult Patients with Hemophilia A.

Myungshin Oh, PhD, Sven Björkman, PhD, Phillip Schroth, Sandor Fritsch, PhD, Peter Collins, MD, Kathelijn Fischer, MD, PhD, MSc, Victor S. Blanchette, MD, Kathleen M. Casey, PhD, Gerald Spotts, PhD, Bruce M. Ewenstein, MD, PhD

Blood (2009) 114 (22): 3492.

https://doi.org/10.1182/blood.V114.22.3492.3492

Published: 2009

Journal Articles

Effect of Normal Variation in Factor VIII Pharmacokinetics on Prophylactic Dosing Requirements in Severe Classical Hemophilia.

Peter Collins, Kathelijn Fischer, MD, PhD, MSC, Victor S. Blanchette, FRCP, Sven Björkman, Myungshin Oh, Phillip Schroth, Kathleen M. Casey, PhD, Gerald Spotts, PhD, Sandor Fritsch, Bruce M. Ewenstein, MD, PhD

Blood (2008) 112 (11): 1222.

https://doi.org/10.1182/blood.V112.11.1222.1222

Published: 2008

Journal Articles

Internal and External Determinants of Bleeding Patterns on Prophylaxis for Severe Haemophilia A.

Kathelijn Fischer, MD, PhD, Peter Collins, MD, Jan Astermark, MD, Victor S. Blanchette, MD, Sven Bjorkman, PhD, Myungshin Oh, PhD, Phillip Schroth, Sandor Fritsch, PhD, Kathleen M. Casey, PhD, Gerald Spotts, PhD, Bruce M. Ewenstein, MD, PhD

Blood (2007) 110 (11): 1145.

https://doi.org/10.1182/blood.V110.11.1145.1145

Published: 2007

Journal Articles

Clinical Implications of Pharmacokinetic Variables in the Management of Patients with Severe Hemophilia A.

Peter W. Collins, MD, Victor Blanchette, MD, Kathelijn Fischer, MD, Jan Astermark, MD, Phillip Schroth, Sandor Fritsch, PhD, Bruce M. Ewenstein, MD, PhD

Blood (2006) 108 (11): 1041.

https://doi.org/10.1182/blood.V108.11.1041.1041

Published: 2006

Journal Articles

Characterization of the Pharmacokinetics of rFVIII in Young Pre-School Children with Hemophilia, Including an Analysis of the Influence of Age and Body Weight.

Victor Blanchette, MD, Amy D. Shapiro, MD, Raina Liesner, BChir, Fernando Hernandez, MD, Anastassios D. Retzios, PhD, Phillip Schroth, CStat, Sandor Fritsch, Gerald Spotts, PhD, Bruce M. Ewenstein, MD, PhD

Blood (2004) 104 (11): 3084.

https://doi.org/10.1182/blood.V104.11.3084.3084

Published: 2004

NARROW

Population pharmacokinetics of recombinant factor VIII: the relationships of pharmacokinetics to age and body weight

Use of a Population Pharmacokinetic Model of ADVATE In Pediatric and Adult Patients with Hemophilia A Permits Limited Blood Sampling for Individual Dose Tailoring.

Population Pharmacokinetic Model of ADVATE in Pediatric and Adult Patients with Hemophilia A.

Effect of Normal Variation in Factor VIII Pharmacokinetics on Prophylactic Dosing Requirements in Severe Classical Hemophilia.

Internal and External Determinants of Bleeding Patterns on Prophylaxis for Severe Haemophilia A.

Clinical Implications of Pharmacokinetic Variables in the Management of Patients with Severe Hemophilia A.

Characterization of the Pharmacokinetics of rFVIII in Young Pre-School Children with Hemophilia, Including an Analysis of the Influence of Age and Body Weight.

Email alerts

ASH Publications

American Society of Hematology

Population pharmacokinetics of recombinant factor VIII: the relationships of pharmacokinetics to age and body weight

Use of a Population Pharmacokinetic Model of ADVATE In Pediatric and Adult Patients with Hemophilia A Permits Limited Blood Sampling for Individual Dose Tailoring.

Population Pharmacokinetic Model of ADVATE in Pediatric and Adult Patients with Hemophilia A.

Effect of Normal Variation in Factor VIII Pharmacokinetics on Prophylactic Dosing Requirements in Severe Classical Hemophilia.

Internal and External Determinants of Bleeding Patterns on Prophylaxis for Severe Haemophilia A.

Clinical Implications of Pharmacokinetic Variables in the Management of Patients with Severe Hemophilia A.

Characterization of the Pharmacokinetics of rFVIII in Young Pre-School Children with Hemophilia, Including an Analysis of the Influence of Age and Body Weight.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only